BioSpace News Archive

Ambulatory Surgery Center operators have a unique hybrid offering to leverage. Simplify ASC has announced it has completed its acquisition of PhyBus RCM, combining the latter’s revenue cycle management services with its proprietary EHR and Practice Management platform to create an operationally-focused solution for ASCs.

Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, today announced it has entered into an exclusive license agreement with Dermira, Inc., a wholly-owned subsidiary of Eli Lilly and Company, to develop and commercialize three development programs for the treatment of various inflammatory disea

Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, today announced the creation of a United States subsidiary and the appointment of Joel Duckworth, an accomplished veteran of the digital pathology market, as its Chief Revenue Officer for the Americas.

INVO Bioscience, Inc. (NASDAQ: INVO) (“Company”) (‘INVO”), a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System, INVOcell®, an effective and a

Athos Therapeutics, a late pre-clinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with autoimmune diseases and cancer, announced today its Chief Business Officer, Keith Hoffman PhD, will participate in both the Biotech Showcase and BIO @ JPM virtual partnering conferenc

Funding to accelerate global expansion of installed base and deliver new solutions at the convergence of single-cell biology and proteomics

Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that specialty manufacturer Octapharma USA, Inc. has selected the Model N Revenue Management Cloud for Life Sciences, including Model N’s Provide

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 9:10 a.m. ET (6:10 a.m. PT). The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com , in the “Investors” section under the “News and Events” page. A replay of the conference webcast will be archived on the compa

Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, today announced the expansion of its leadership team with the appointment of a Chief Scientific Officer and two additional Board members. Virometix filled a vacancy in its management team with the appointment of Dr. Lil

Co-Diagnostics, Inc. announced that Company CEO Dwight Egan will participate in a panel discussion on diagnostics and devices hosted by Scott Gottlieb, M.D., at the H.C. Wainwright & Co. BioConnect 2021 Conference, being held January 11-14.